NCT00423059 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy Status COMPLETED Phase NA
NCT00414999 A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00411333 Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy Status COMPLETED Phase EARLY_PHASE1
NCT00407849 Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema Status UNKNOWN Phase PHASE1/PHASE2
NCT00407108 Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy Status WITHDRAWN Phase PHASE3
NCT00403195 Clinical and Pathophysiological Description of Ocular Ischemic Syndrome Status COMPLETED Phase N/A
NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy Status COMPLETED Phase PHASE1
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT00370721 Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR) Status UNKNOWN Phase PHASE3
NCT00355680 Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE3
NCT00347698 Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy Status WITHDRAWN Phase PHASE2/PHASE3
NCT00337298 The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes Status COMPLETED Phase NA
NCT00336323 A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) Status COMPLETED Phase PHASE2
NCT00295828 A Pilot Study for the Treatment of Iris Neovascularization With Macugen Status COMPLETED Phase PHASE1
NCT00248157 Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Status TERMINATED Phase PHASE3